Cobalamin Deficiency in Children and Adolescents with Sickle Cell Disease.
Ontology highlight
ABSTRACT: Background/Objective: Cobalamin (B12) deficiency is reported in 18% of adults with sickle cell disease (SCD) and only 10% without SCD; limited data are available on children. Diagnosing B12 deficiency is challenging given the lack of an established gold standard method of assessment and the unique renal features of SCD. B12 metabolism can be impacted by the clinical use of nitrous oxide gas (N2O), which is a standard therapy for SCD pain in some European countries. In response to emerging reports of neurologic sequalae in patients with SCD receiving N2O, we evaluated the prevalence of B12 deficiency in children with SCD pain. Methods: Secondary analysis of prospective blood and urine samples in children aged 3-
SUBMITTER: Hatabah D
PROVIDER: S-EPMC11819659 | biostudies-literature | 2025 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA